Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain
Abstract
An increasing body of evidence indicates that: 1) the endocannabinoid anandamide (AEA) and other unsaturated N-acylethanolamines (NAEs), 2) 12-(S)-lipoxygenase (12-LOX) products of arachidonic acid, and 3) unsaturated N-acyldopamines (NADAs), act as endogenous ligands of transient receptor potential vanilloid type 1 (TRPV1) channels at intracellular binding sites. AEA is synthesized and released "on demand" in neurons from its membrane precursor, N-arachidonoyl-phosphatidylethanolamine, by an N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD), and is inactivated by intracellular hydrolysis by fatty acid amide hydrolase (FAAH), whereas catechol-O-methyl-transferase (COMT) was suggested to inactivate NADAs. However, it is not known whether these enzymes or 12-LOX co-localize to any extent with TRPV1 receptors in the brain. In this study we used immunohistochemical techniques (single peroxidase and double immunofluorescence staining), and analyzed the localization of the TRPV1 channel in mouse hippocampal and cerebellar neurons with respect to NAPE-PLD, FAAH, 12-LOX and COMT. Cycloxygenase-2 (COX-2), another putative AEA-degrading enzyme, was also studied. Co-localization between TRPV1 and either NAPE-PLD or FAAH, COX-2, 12-LOX and COMT was found in Ammon's horn (CA3) hippocampal pyramidal neurons and (with the exception of 12-LOX) in some Purkinje cells. At the cellular level, both anabolic and catabolic enzymes appeared as fine grains with immunoperoxidase labeling and were observed in the somatodendritic compartment of CA3 pyramidal cells as well as (with the exception of 12-LOX) in the cytoplasm of Purkinje neurons, in which FAAH and COX-2 immunoreactivities were, however, preferentially localized in the large extension of the dendritic arbor. Our data agree with the hypothesis that, in potential "endovanillergic" neurons, endogenous TRPV1 agonists, and AEA in particular, act as intracellular mediators by being produced from and/or degraded by the same mouse brain cells that express TRPV1 receptors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
COX-2 is primarily expressed postsynaptically and localizes to dendritic spines and dendrites in an expression pattern strikingly similar to that of FAAH.
“COX-2 is primarily expressed postsynaptically and localizes to dendritic spines and dendrites in an expression pattern strikingly similar to that of FAAH (Cristino et al., 2008).”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Cristino et al., 2008
Cites
1 retracted
Ahluwalia, J., Yaqoob, M., Urbán, L., Bevan, S., & Nagy, I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01550.x · Cited by 82 · see citing works
RetractedThe capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. J. (1997) · Nature · doi:10.1038/39807 · Cited by 9,132 · see citing works
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,737 · see citing works
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · see citing works
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · see citing works
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · see citing works
Vanilloid (Capsaicin) Receptors and Mechanisms
SZALLASI, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903 · see citing works
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · see citing works
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works
Huang, S. M., Bisogno, T., Trevisani, M., Al‐Hayani, A., PETROCELLIS, L. D., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 962 · see citing works
Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers
Jordt, S., & Julius, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00637-2 · Cited by 881 · see citing works
Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850 · see citing works
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 800 · see citing works
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775 · see citing works
Kaufmann, W. E., Worley, P. F., Pegg, J. A., Bremer, M., & Isakson, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2317 · Cited by 593 · see citing works
Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561 · see citing works
Characterization of inducible cyclooxygenase in rat brain
Breder, C., Dewitt, D., & Kraig, R. (1995) · The Journal of comparative neurology · doi:10.1002/cne.903550208 · Cited by 550 · see citing works
Cristino, L., PETROCELLIS, L. D., Pryce, G., Baker, D., Guglielmotti, V., & Marzo, V. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.074 · Cited by 489 · see citing works
A biosynthetic pathway for anandamide
Liu, J., Wang, L., Harvey-White, J. D., Osei‐Hyiaman, D., Razdan, R. J., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 468 · see citing works
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
Tóth, A., Boczán, J., Kedei, N., Lizanecz, E., Bagi, Z. A., Papp, Z., Edes, I. F., Csiba, L., & Blumberg, P. M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.003 · Cited by 452 · see citing works
Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2
Yu, M., Ives, D., & Ramesha, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21181 · Cited by 406 · see citing works
van der Stelt, M., & Marzo, V. D. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04081.x · Cited by 388 · see citing works
Bisogno, T., Melck, D. J., BOBROV, M. Y., Gretskaya, N. M., Безуглов, В. В., PETROCELLIS, L. D., & Marzo, V. D. (2000) · Biochemical Journal · doi:10.1042/bj3510817 · Cited by 382 · see citing works
Biochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Marzo, V. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 381 · see citing works
Marsch, R., Foeller, E., Rammes, G., Bunck, M., Kössl, M., Holsboer, F., Zieglgänsberger, W., Landgraf, R., Lutz, B., & Wotjak, C. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3303-06.2007 · Cited by 359 · see citing works
Molecular Determinants of Vanilloid Sensitivity in TRPV1
Gavva, N. R., Klionsky, L., Qu, Y., Shi, L., Tamir, R., Edenson, S., Zhang, T. J., Viswanadhan, V. N., Tóth, A., Pearce, L. V., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312577200 · Cited by 356 · see citing works
PETROCELLIS, L. D., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi‐Agrò, A., & Marzo, V. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 350 · see citing works
Leung, D., Saghatelian, A., Simon, G. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi060163l · Cited by 348 · see citing works
Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347 · see citing works
N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia
Chu, C. J., Huang, S. M., PETROCELLIS, L. D., Bisogno, T., Ewing, S. A., Miller, J. D., Zipkin, R. E., Daddario, N., Appendino, G., Marzo, V. D., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211231200 · Cited by 345 · see citing works
Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernández‐Ruíz, J., & Marzo, V. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 313 · see citing works
Ueda, N., Kurahashi, Y., Yamamoto, S., & Tokunaga, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23823 · Cited by 303 · see citing works
Maione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., & Marzo, V. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093286 · Cited by 293 · see citing works
Endocannabinoids and the regulation of their levels in health and disease
Marzo, V. D., & Petrosino, S. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32803dbdec · Cited by 289 · see citing works
Roberts, J. C., Davis, J. B., & Benham, C. D. (2003) · Brain Research · doi:10.1016/j.brainres.2003.10.001 · Cited by 286 · see citing works
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M., Vellani, V., PETROCELLIS, L. D., Moriello, A. S., Campi, B., McNaughton, P. A., Geppetti, P., & Marzo, V. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600784 · Cited by 243 · see citing works
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus
Kim, J., & Alger, B. E. (2004) · Nature Neuroscience · doi:10.1038/nn1262 · Cited by 238 · see citing works
Marzo, V. D., PETROCELLIS, L. D., Fezza, F., Ligresti, A., & Bisogno, T. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0349 · Cited by 238 · see citing works
Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00087-s · Cited by 233 · see citing works
New perspectives on enigmatic vanilloid receptors
SZALLASI, A., & Marzo, V. D. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01630-1 · Cited by 216 · see citing works
Anandamide Hydrolysis by Human Cells in Culture and Brain
Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G. A., Vliegenthart, J. F. G., & Finazzi‐Agrò, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32332 · Cited by 196 · see citing works
Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
Rice, A. S. C., Farquhar-Smith, W. P., & Nagy, I. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0362 · Cited by 183 · see citing works
Endogenous Unsaturated C18 N-Acylethanolamines Are Vanilloid Receptor (TRPV1) Agonists
Movahed, P., Jönsson, B., Birnir, B., Wingstrand, J. A., Dyhring, T., Ermund, A., Sterner, O., Zygmunt, P. M., & Högestätt, E. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507429200 · Cited by 172 · see citing works
Sanchez, J. F., Krause, J. E., & Cortright, D. N. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00373-6 · Cited by 169 · see citing works
Cannabinoids: a real prospect for pain relief
Iversen, L. L. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00120-5 · Cited by 162 · see citing works
Prostamides (prostaglandin‐ethanolamides) and their pharmacology
Woodward, D. F., Liang, Y., & Krauss, A. H. ‐. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707434 · Cited by 157 · see citing works
Marinelli, S., Marzo, V. D., Florenzano, F., Fezza, F., Viscomi, M. T., van der Stelt, M., Bernardi, G., Molinari, M., Maccarrone, M., & Mercuri, N. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301118 · Cited by 155 · see citing works
Price, T. J., Patwardhan, A. M., Akopian, A. N., Hargreaves, K., & Flores, C. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705711 · Cited by 146 · see citing works
Liapi, A., & Wood, J. N. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04270.x · Cited by 142 · see citing works
Immunohistochemical demonstration of catechol-O-methyltransferase in mammalian brain
Kaplan, G. P., Hartman, B. K., & Creveling, C. R. (1979) · Brain Research · doi:10.1016/0006-8993(79)90819-9 · Cited by 137 · see citing works
Oxidative Metabolism of Endocannabinoids by COX-2
Kozak, K. R., Prusakiewicz, J. J., & Marnett, L. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453081 · Cited by 136 · see citing works
Matsumoto, M., Weickert, C. S., Beltaifa, S., Kolachana, B. S., Chen, J., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300218 · Cited by 133 · see citing works
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
Matias, I., Chen, J., PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H. ‐., Shi, L., Protzman, C. E., Li, C., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061705 · Cited by 132 · see citing works
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
Al-Hayani, A., Wease, K. N., Ross, R. A., Pertwee, R. G., & Davies, S. N. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00145-9 · Cited by 127 · see citing works
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Brandi, I., Jefferson, R. G., Winckler, R., Davis, J. B., DASSE, O. A., Mahadevan, A., Razdan, R. K., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4354 · Cited by 120 · see citing works
Uz, T., Pesold, C., Longone, P., & Manev, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.439 · Cited by 114 · see citing works
Feinmark, S. J., Begum, R., Tsvetkov, E., Goussakov, I. V., Funk, C. D., Siegelbaum, S. A., & Bolshakov, V. Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11427.2003 · Cited by 107 · see citing works
Canals, S., Casarejos, M. J., de Bernardo, S., Rodríguez‐Martín, E., & Mena, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213174200 · Cited by 103 · see citing works
The Tissue Distribution and Functional Characterization of Human VR1
Cortright, D. N., Crandall, M., Sanchez, J. F., Zou, T., Krause, J. E., & White, G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4482 · Cited by 102 · see citing works
Pharmacological characterization of vanilloid receptor located in the brain
Szabó, T. G., Bı́ró, T., Gonzalez, A. F., Palkovits, M., & Blumberg, P. M. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00313-8 · Cited by 90 · see citing works
Slanina, K. A., & Schweitzer, P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.019 · Cited by 89 · see citing works
Endocannabinoids restrict hippocampal long-term potentiation via CB1
Slanina, K. A., Roberto, M., & Schweitzer, P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.021 · Cited by 89 · see citing works
Endocannabinoids in pain modulation
Walker, J. M., & Huang, S. M. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0361 · Cited by 79 · see citing works
Karhunen, T., Tilgmann, C., Ulmanen, I., & Panul, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11337-v · Cited by 75 · see citing works
Nishiyama, M., Watanabe, T., Ueda, N., Tsukamoto, H., & Watanabe, K. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.1.8417106 · Cited by 71 · see citing works
Morishita, J., Okamoto, Y., Tsuboi, K., Ueno, M., Sakamoto, H., Nobuhiro Maekawa, A., & Ueda, N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03234.x · Cited by 70 · see citing works
Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals
Köfalvi, A., Oliveira, C. R., & Cunha, R. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.030 · Cited by 64 · see citing works
Benninger, F., Freund, T. F., & Hájos, N. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.008 · Cited by 35 · see citing works
Maccarrone, M., Salvati, S., Bari, M., & Finazzi‐Agrò, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3869 · Cited by 35 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529 · see citing works
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,126 · see citing works
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970 · see citing works
Self-citationNeurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 663 · see citing works
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 484 · see citing works
Marzo, V. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.010 · Cited by 367 · see citing works
Chávez, A. E., Chiu, C. Q., & Castillo, P. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2684 · Cited by 351 · see citing works
Remote Control of Neuronal Signaling
Rogan, S. C., & Roth, B. L. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003020 · Cited by 339 · see citing works
Phytocannabinoids as novel therapeutic agents in {CNS} disorders.
Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312 · see citing works
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290 · see citing works
An introduction to the endocannabinoid system: from the early to the latest concepts
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 249 · see citing works
Hot flash: TRPV channels in the brain
Kauer, J. A., & Gibson, H. E. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.006 · Cited by 235 · see citing works
The endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9177-z · Cited by 216 · see citing works
Biology of endocannabinoid synthesis system
Wang, J., & Ueda, N. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.002 · Cited by 182 · see citing works
Endocannabinoids in the retina: From marijuana to neuroprotection
Yazulla, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.002 · Cited by 178 · see citing works
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S., & Mackie, K. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 177 · see citing works
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight
Marzo, V. D. (2010) · Nature Neuroscience · doi:10.1038/nn.2720 · Cited by 171 · see citing works
Ueda, N., Tsuboi, K., & Uyama, T. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.02.003 · Cited by 164 · see citing works
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 150 · see citing works
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses
Kim, J., & Alger, B. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2517 · Cited by 149 · see citing works
From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 142 · see citing works
Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4112-14.2015 · Cited by 133 · see citing works
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126 · see citing works
Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 126 · see citing works
Hermanson, D. J., Gamble‐George, J., Marnett, L. J., & Patel, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.006 · Cited by 121 · see citing works
Enzymological studies on the biosynthesis of N-acylethanolamines
Ueda, N., Tsuboi, K., & Uyama, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.010 · Cited by 112 · see citing works
Moreira, F. A., de Aguiar, D. C., Terzian, A. L. B., Guimarães, F. S., & Wotjak, C. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.046 · Cited by 112 · see citing works
Myöhänen, T. T., Schendzielorz, N., & Männistö, P. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06723.x · Cited by 108 · see citing works
FAAH and anandamide: is 2-AG really the odd one out?
Marzo, V. D., & Maccarrone, M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.001 · Cited by 107 · see citing works
Giordano, C., Cristino, L., Luongo, L., Siniscalco, D., Petrosino, S., Piscitelli, F., Marabese, I., Gatta, L., Rossi, F., Imperatore, R., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr328 · Cited by 100 · see citing works
TRPV1 in the Central Nervous System: Synaptic Plasticity, Function, and Pharmacological Implications
Edwards, J. G. (2014) · Springer eBooks · doi:10.1007/978-3-0348-0828-6_3 · Cited by 90 · see citing works
TRPV1 channels control synaptic plasticity in the developing superior colliculus
Maione, S., Cristino, L., Al, M., Georgiou, A. L., Starowicz, K., Salt, T. E., & Marzo, V. D. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.171900 · Cited by 88 · see citing works
Llorente, R., Llorente‐Berzal, A., Petrosino, S., Marco, E. M., Guaza, C., Prada, C., López‐Gallardo, M., Marzo, V. D., & Viveros, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20666 · Cited by 85 · see citing works
Role of endocannabinoids and endovanilloids in Ca2+ signalling
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.03.003 · Cited by 80 · see citing works
Endocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 78 · see citing works
CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release
Maleńczyk, K., Jazurek, M., Keimpema, E., Silvestri, C., Janikiewicz, J., Mackie, K., Marzo, V. D., Rędowicz, M. J., Harkany, T., & Dobrzyń, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478354 · Cited by 74 · see citing works
Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Marzo, V. D., & Przewłocka, B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.021 · Cited by 74 · see citing works
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Morena, M., Nastase, A. S., Santori, A., Cravatt, B. F., Shansky, R. M., & Hill, M. N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15341 · Cited by 70 · see citing works
Neuronal populations mediating the effects of endocannabinoids on stress and emotionality
Häring, M., Guggenhuber, S., & Lutz, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.035 · Cited by 70 · see citing works
Fawley, J. A., Hofmann, M. E., & Andresen, M. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0315-14.2014 · Cited by 65 · see citing works
Abdelhamid, R. E., Kovács, K. J., Nunez, M. G., & Larson, A. A. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.10.006 · Cited by 66 · see citing works
Lever, I. J., Robinson, M., Cibelli, M., Paule, C. C., Sántha, P., Yee, L., Hunt, S. P., Cravatt, B. F., Elphick, M. R., Nagy, I., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4071-08.2009 · Cited by 63 · see citing works
Chapter 1 Enzymatic Formation of Anandamide
Okamoto, Y., Tsuboi, K., & Ueda, N. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81001-7 · Cited by 61 · see citing works
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
Starowicz, K., & Przewłocka, B. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0392 · Cited by 57 · see citing works
Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels
Aguiar, D. C., Moreira, F. A., Terzian, A. L., Fogaça, M. V., Lisboa, S. F., Wotjak, C. T., & Guimaraes, F. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.026 · Cited by 57 · see citing works
TRPV1 acts as a synaptic protein and regulates vesicle recycling
Goswami, C., Rademacher, N., Smalla, K., Kalscheuer, V. M., Ropers, H., Gundelfinger, E. D., & Hucho, T. B. (2010) · Journal of Cell Science · doi:10.1242/jcs.065144 · Cited by 57 · see citing works
Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
Melis, M., Carta, G., Pistis, M., & Banni, S. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010012 · Cited by 56 · see citing works
Psychopharmacology of the endocannabinoids: far beyond anandamide
Pamplona, F. A., & Takahashi, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405357 · Cited by 57 · see citing works
Hennebelle, M., Zhang, Z., Metherel, A. H., Kitson, A. P., Otoki, Y., Richardson, C. E., Yang, J., Lee, K. S. S., Hammock, B. D., Zhang, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02914-7 · Cited by 53 · see citing works
Bennion, D. M., Jensen, T., Walther, C., Hamblin, J., Wallmann, A., Couch, J., Blickenstaff, J., Castle, M., Dean, L., Beckstead, S., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.018 · Cited by 52 · see citing works
Maione, S., Starowicz, K., Cristino, L., Guida, F., Palazzo, E., Luongo, L., Rossi, F., Marabese, I., de Novellis, V., & Marzo, V. D. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91225.2008 · Cited by 51 · see citing works
Endogenous cannabinoid signaling at inhibitory interneurons
Younts, T. J., & Castillo, P. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.006 · Cited by 50 · see citing works
Hohmann, U., & Dehghani, F. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0015 · Cited by 50 · see citing works
Zhang, H., Hilton, D. A., Hanemann, C. O., & Zajicek, J. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00477.x · Cited by 50 · see citing works
Merrill, C. B., Friend, L. N., Newton, S. T., Hopkins, Z. H., & Edwards, J. G. (2015) · Scientific Reports · doi:10.1038/srep16176 · Cited by 49 · see citing works
Koch, M., Kreutz, S., Böttger, C., Grabiec, U., Ghadban, C., Korf, H., & Dehghani, F. (2010) · Hippocampus · doi:10.1002/hipo.20772 · Cited by 45 · see citing works
Friend, L. N., Weed, J., Sandoval, P. J., Nufer, T. M., Ostlund, I., & Edwards, J. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0190-17.2017 · Cited by 44 · see citing works
Brain TRPV1: a depressing TR(i)P down memory lane?
Marzo, V. D., Gobbi, G., & SZALLASI, A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.004 · Cited by 37 · see citing works
Hegyi, Z., Holló, K., Kis, G. N., Mackie, K., & Antal, M. (2012) · Glia · doi:10.1002/glia.22351 · Cited by 33 · see citing works
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 32 · see citing works
Rojo-Bustamante, E., Abellanas, M. A., Clavero, P., Thiolat, M.-L., Li, Q., Luquín, M. R., Bézard, E., & Aymerich, M. S. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.019 · Cited by 30 · see citing works
Placzek, E. A., Okamoto, Y., Ueda, N., & Barker, E. L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.047 · Cited by 28 · see citing works
Cerebellar Endocannabinoids: Retrograde Signaling from Purkinje Cells
Marcaggi, P. (2014) · The Cerebellum · doi:10.1007/s12311-014-0629-5 · Cited by 27 · see citing works
Carletti, F., Gambino, G., Rizzo, V., Ferraro, G., & Sardo, P. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.02.005 · Cited by 27 · see citing works
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis
Paltser, G., Liu, X. J., Yantha, J., Winer, S., Tsui, H., Wu, P., Maezawa, Y., Cahill, L. S., Laliberté, C. L., Ramagopalan, S. V., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00329 · Cited by 26 · see citing works
Grabiec, U., Koch, M., Kallendrusch, S., Kraft, R., Hill, K., Merkwitz, C., Ghadban, C., Lutz, B., Straiker, A. J., & Dehghani, F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.023 · Cited by 25 · see citing works
Navarrete, C. M., Pérez, M., de Vinuesa, A. G., Collado, J. A., Fiebich, B. L., Calzado, M. A., & Muñóz, E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.014 · Cited by 24 · see citing works
Light, A. R., Vierck, C. J., & Light, K. C. (2011) · Europe PMC (PubMed Central) · Cited by 22 · see citing works
Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13997 · Cited by 25 · see citing works
Antonazzo, M., Botta, M. F., Bengoetxea, H., Ruíz-Ortega, J. Á., & Morera‐Herreras, T. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.06.012 · Cited by 22 · see citing works
Comparative Effects of Heterologous TRPV1 and TRPM8 Expression in Rat Hippocampal Neurons
Crawford, D. C., Moulder, K. L., Gereau, R. W., Story, G. M., & Mennerick, S. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008166 · Cited by 22 · see citing works
Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice
Pamplona, F. A., Menezes‐de‐Lima, O., & Takahashi, R. N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.050 · Cited by 22 · see citing works
Cyclooxygenase-2 inhibition prevents stress induced amygdala activation and anxiety-like behavior
Morgan, A., Gaulden, A. D., Altemus, M., Williford, K. M., Centanni, S. W., Winder, D. G., & Patel, S. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.046 · Cited by 17 · see citing works
Sagheddu, C., Torres, L. H., Marcourakis, T., & Pistis, M. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.588660 · Cited by 15 · see citing works
Endocannabinoid-Binding Receptors as Drug Targets
Gómez‐Cañas, M., Rodríguez‐Cueto, C., Satta, V., Hernández-Fisac, I., Navarro, E., & Fernández‐Ruíz, J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_6 · Cited by 17 · see citing works
Nagy, B., Fedonidis, C., Photiou, A., Wahba, J., Paule, C. C., Ma, D., Buluwela, L., & Nagy, I. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.047 · Cited by 17 · see citing works
Reguero, L., Puente, N., Elezgarai, I., Ramos, A., Gerrikagoitia, I., Bueno‐López, J., Doñate-Oliver, F., & Grandes, P. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1174-x · Cited by 17 · see citing works
Seillier, A., & Giuffrida, A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.032 · Cited by 16 · see citing works
Mizuno, I., & Matsuda, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00246-y · Cited by 15 · see citing works
Merrill, C. B., McNeil, M., Williamson, R. C., Poole, B., Nelson, B., Sudweeks, S. N., & Edwards, J. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.012 · Cited by 14 · see citing works
Canduela, M.-J., Mendizabal-Zubiaga, J., Puente, N., Reguero, L., Elezgarai, I., Ramos-Uriarte, A., Gerrikagoitia, I., & Grandes, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119401 · Cited by 13 · see citing works
Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases
Pistis, M., & Muntoni, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_11 · Cited by 12 · see citing works
Friend, L. N., Williamson, R. C., Merrill, C. B., Newton, S. T., Christensen, M. T., Petersen, J., Wu, B., Ostlund, I., & Edwards, J. G. (2019) · Molecules · doi:10.3390/molecules24071306 · Cited by 12 · see citing works
Czikora, Á., Lizanecz, E., Boczán, J., Daragó, A., Papp, Z. L., Edes, I. F., & Tóth, A. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.12.016 · Cited by 10 · see citing works
Cristino, L., Imperatore, R., & Marzo, V. D. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.05.003 · Cited by 9 · see citing works
Durydivka, O., Palivec, P., Gazdarica, M., Mackie, K., Blahoš, J., & Kuchař, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-58845-7 · Cited by 9 · see citing works
5-Lipoxygenase in mouse cerebellar Purkinje cells
Chen, H., Dzitoyeva, S., & Manev, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.019 · Cited by 8 · see citing works
Marzo, V. D. (2011) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0023403 · Cited by 8 · see citing works
Bertacchini, G. L., Sonego, A. B., Lisboa, S. F. D. S., Lagatta, D. C., & Resstel, L. B. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17384 · Cited by 5 · see citing works
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS
Kouchaeknejad, A., van der Walt, G., de Donato, M. H., & Puighermanal, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115829 · Cited by 6 · see citing works
Bialecki, J., Weilinger, N. L., Lohman, A. W., Vecchiarelli, H. A., Robinson, J. H. B., Huguet, J. E., Medizabal-Zubiaga, J., Werner, A. C., Grandes, P., Teskey, G. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/263640 · Cited by 5 · see citing works
Cannabinoids and Synaptic Transmission in the Cerebellum
Myoga, M. H., & Regehr, W. G. (2012) · Springer eBooks · doi:10.1007/978-3-030-23810-0_39 · Cited by 3 · see citing works
PETROCELLIS, L. D., & Marzo, V. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-420126-2.00005-5 · Cited by 3 · see citing works
Endocannabinoid Modulation in Headache: Mechanisms, Models, and Translational Therapies
Wen, J., & Zhang, Y. (2026) · Cells · doi:10.3390/cells15040331 · Cited by 2 · see citing works
Anandamide and Other Acylethanolamides
Petrosino, S., & Marzo, V. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_5 · Cited by 2 · see citing works
Wang, F.-Y., Wei, L., Wang, P., Chen, W., Chen, Z., Zhou, Z.-Q., Zhu, G., Gong, Q., Qin, L.-P., Yang, L., et al. (2026) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2026.118409 · Cited by 1 · see citing works
Temperature-Sensitive Transient Receptor Potential Channels as Ionotropic Cannabinoid Receptors
Marzo, V. D., & PETROCELLIS, L. D. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_8 · Cited by 1 · see citing works
Dutta, R. (2021) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001049 · Cited by 1 · see citing works
TRPV1 in Neuropathic Pain and Neurological and Neuropsychiatric Disorders
Palazzo, E., Starowicz, K., Maione, S., & Marzo, V. D. (2010) · Wiley eBooks · doi:10.1002/9780470588284.ch10
- Authors
- Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V.
- Affiliations
- Institute of Applied Science and Intelligent Systems (IT)
- Istituto di Chimica Biomolecolare (IT)
- Kagawa University (JP)
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 151
- Issue
- 4
- Pages
- 955-968
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2024356032
- Cited by
- 115
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 11 · 2016: 3 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 11
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Keywords
- anandamide, endocannabinoids, endovanilloids, TRPV1, fatty acid amide hydrolase, 12-lipoxygenase, catechol-O-methyltransferase, cyclooxygenase-2, N-acylethanolamines, hippocampus, cerebellar cortex, Purkinje cells, CA3 pyramidal cells, enzyme colocalization
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Arachidonate 12-Lipoxygenase, Catechol O-Methyltransferase, Cerebellar Cortex, Glutamate Decarboxylase, Hippocampus, Male, Neurons, Phospholipase D, TRPV Cation Channels, Mice, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review